| __timestamp | Agios Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 5078000000 |
| Thursday, January 1, 2015 | 35992000 | 4717000000 |
| Friday, January 1, 2016 | 50714000 | 5096000000 |
| Sunday, January 1, 2017 | 71124000 | 4986000000 |
| Monday, January 1, 2018 | 114145000 | 4214000000 |
| Tuesday, January 1, 2019 | 132034000 | 3806000000 |
| Wednesday, January 1, 2020 | 149070000 | 3671000000 |
| Friday, January 1, 2021 | 121445000 | 3528000000 |
| Saturday, January 1, 2022 | 121673000 | 3445000000 |
| Sunday, January 1, 2023 | 119903000 | 3498000000 |
| Monday, January 1, 2024 | 156784000 | 3702000000 |
Unveiling the hidden dimensions of data
In the competitive pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. From 2014 to 2023, Teva Pharmaceutical Industries Limited and Agios Pharmaceuticals, Inc. have shown contrasting approaches. Teva, a global leader, consistently reported higher SG&A expenses, peaking at approximately $5 billion in 2016. In contrast, Agios, a smaller biotech firm, maintained a more modest SG&A profile, with expenses reaching around $149 million in 2020. Over the decade, Teva's SG&A costs decreased by about 32%, while Agios saw a 526% increase, reflecting its growth phase. This data highlights Teva's strategic cost-cutting measures and Agios's investment in expansion. Understanding these trends offers valuable insights into each company's operational strategies and financial health.
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Bio-Techne Corporation
Teva Pharmaceutical Industries Limited vs Viking Therapeutics, Inc.: SG&A Expense Trends
Teva Pharmaceutical Industries Limited vs Catalyst Pharmaceuticals, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc.
Comparing SG&A Expenses: Teva Pharmaceutical Industries Limited vs Bausch Health Companies Inc. Trends and Insights
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Mesoblast Limited
Breaking Down SG&A Expenses: Teva Pharmaceutical Industries Limited vs Iovance Biotherapeutics, Inc.
Teva Pharmaceutical Industries Limited vs Celldex Therapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Alpine Immune Sciences, Inc. vs Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: Bausch Health Companies Inc. vs Agios Pharmaceuticals, Inc. Trends and Insights
Selling, General, and Administrative Costs: Arrowhead Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: Agios Pharmaceuticals, Inc. vs Travere Therapeutics, Inc. Trends and Insights